Modular Medical, Inc. Overview
Pro stress-test →Modular Medical is a medical device company focused on the design, development, and commercialization of insulin pumps to increase pump adoption in the diabetes marketplace. The company's flagship product, Pivot, received FDA 510(k) clearance on April 9, 2026, positioning Modular Medical to enter a significant market opportunity within diabetes care delivery.
Strategic Profile
Pro stress-test →Pivot is a first-of-its-kind two-part tubeless pump with a removable 3 mL reservoir, disposable battery, and smartphone bolus/control, with initial production capacity for ~6,000 users and expected initial customer shipments by end of Q2 2026. The company targets what it describes as the "almost-pumper" segment—individuals not yet using insulin pumps despite medical need—representing a $3 billion addressable market opportunity.
Competitive Landscape
Pro stress-test →The insulin pump market includes established competitors such as Medtronic (Guardian/630G series) and Tandem Diabetes (t:slim X2), alongside newer entrants targeting simplified pump adoption. Modular Medical differentiates through its removable two-part tubeless design and smartphone connectivity targeting non-adopters. The company faces significant scale and market education challenges as a development-stage entrant against established distribution networks.
Industry Context
Modular Medical, Inc. operates in Insulin pump medical devices.
Key facts
Founded: N/A · Headquarters: San Diego, US · Employees: N/A · Revenue: N/A · Market cap: N/A